Literature DB >> 10807204

Distinguishing efficacy, individual effectiveness and population effectiveness of therapies.

A Muñoz, S J Gange, L P Jacobson.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10807204     DOI： 10.1097/00002030-200004140-00020

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  13 in total

1.  Efficacy, individual effectiveness, and population effectiveness in substance abuse treatment.

Authors:  G E Woody; A Muñoz
Journal:  Curr Psychiatry Rep       Date:  2000-12       Impact factor: 5.285

Review 2.  The population effectiveness of highly active antiretroviral therapy: are good drugs good enough?

Authors:  Thomas P Giordano; Maria E Suarez-Almazor; Richard M Grimes
Journal:  Curr HIV/AIDS Rep       Date:  2005-11       Impact factor: 5.071

Review 3.  Translating efficacy into effectiveness in antiretroviral therapy: beyond the pill count.

Authors:  Courtney V Fletcher
Journal:  Drugs       Date:  2007       Impact factor: 9.546

4.  Clinically informative measures of the effect of drugs or other interventions.

Authors:  L Rachid Salmi; Samy Suissa; Geneviève Chêne; Roger Salamon
Journal:  Br J Clin Pharmacol       Date:  2008-03-13       Impact factor: 4.335

5.  Effectiveness of highly active antiretroviral therapy among HIV-1 infected women.

Authors:  S J Gange; Y Barrón; R M Greenblatt; K Anastos; H Minkoff; M Young; A Kovacs; M Cohen; W A Meyer; A Muñoz
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

Review 6.  Studying outcomes of intensive care unit survivors: the role of the cohort study.

Authors:  David W Dowdy; Dale M Needham; Pedro A Mendez-Tellez; Margaret S Herridge; Peter J Pronovost
Journal:  Intensive Care Med       Date:  2005-05-21       Impact factor: 17.440

7.  Gender differences in progression to AIDS and death from HIV seroconversion in a cohort of injecting drug users from 1986 to 2001.

Authors:  Manuela García de la Hera; Inmaculada Ferreros; Julia del Amo; Patricia García de Olalla; Santiago Pérez Hoyos; Roberto Muga; Jorge del Romero; Rafael Guerrero; Ildefonso Hernández-Aguado
Journal:  J Epidemiol Community Health       Date:  2004-11       Impact factor: 3.710

8.  Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study.

Authors:  Michael J Silverberg; Mary Elizabeth Gore; Audrey L French; Monica Gandhi; Marshall J Glesby; Andrea Kovacs; Tracey E Wilson; Mary A Young; Stephen J Gange
Journal:  Clin Infect Dis       Date:  2004-08-16       Impact factor: 9.079

9.  HIV disease progression to CD4 count <200 cells/μL and death in Saskatoon, Saskatchewan.

Authors:  Stephanie Konrad; Stuart Skinner; Germain Bukassa Kazadi; Kali Gartner; Hyun June Lim
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

10.  Factors influencing HIV progression in a seroconverter cohort in Madrid from 1985 to 1999.

Authors:  J del Amo; J del Romero; A Barrasa; S Pérez-Hoyos; C Rodríguez; M Díez; S García; V Soriano; J Castilla
Journal:  Sex Transm Infect       Date:  2002-08       Impact factor: 3.519
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.